Show simple item record

dc.contributor.authorMyers-Franchi, Bronwyn
dc.contributor.authorvan der Westhuizen, C.
dc.contributor.authorPool, M.
dc.contributor.authorHornsby, N.
dc.contributor.authorSorsdahl, K.R.
dc.date.accessioned2021-09-24T06:54:26Z
dc.date.available2021-09-24T06:54:26Z
dc.date.issued2021
dc.identifier.citationMyers, B. and van der Westhuizen, C. and Pool, M. and Hornsby, N. and Sorsdahl, K.R. 2021. Responding to COVID-19 threats to trial conduct: lessons learned from a feasibility trial of a psychological intervention for South African adolescents. Trials. 22 (1): Article No. 440.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/85594
dc.identifier.doi10.1186/s13063-021-05400-8
dc.description.abstract

The COVID-19 pandemic has posed challenges to the conduct of clinical trials. Strategies for overcoming common challenges to non-COVID-19 trial continuation have been reported, but this literature is limited to pharmacological intervention trials from high-income settings. The purpose of this paper is to expand the literature to include a low- and middle-income country perspective. We describe the challenges posed by COVID-19 for a randomised feasibility trial of a psychological intervention for adolescents in Cape Town, South Africa, and lessons learned when implementing strategies to facilitate trial continuation in this context. We used a Plan-Do-Study-Act cycle method to explore whether our adaptations were having the desired effect on trial accrual and retention. We found that stakeholder engagement, trial coordination and team communication need to be intensified while testing these procedural changes. We learned that strategies found to be effective in high-income countries required significant adaptation to our resource-constrained setting. The detailed documentation of extraneous influences, procedural changes and trial process information was essential to guiding decisions about which adaptations to retain. This information will be used to examine the potential impact of these changes on study outcomes. We hope that these reflections will be helpful to other trialists from low- and middle-income countries grappling with how to minimise the impact of public health emergencies on their research. Trial registration: The trial is registered with the Pan African Clinical Trials Registry (PACTR20200352214510). Registered 28 February 2020. https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9795.

dc.languageEnglish
dc.publisherBMC
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectMedicine, Research & Experimental
dc.subjectResearch & Experimental Medicine
dc.subjectCOVID-19
dc.subjectAdolescent
dc.subjectMental health
dc.subjectLow- and middle-income country
dc.subjectQuality improvement cycle
dc.subjectCLINICAL-TRIALS
dc.subjectCHALLENGES
dc.subjectSUCCESSES
dc.subjectALCOHOL
dc.titleResponding to COVID-19 threats to trial conduct: lessons learned from a feasibility trial of a psychological intervention for South African adolescents
dc.typeJournal Article
dcterms.source.volume22
dcterms.source.number1
dcterms.source.issn1745-6215
dcterms.source.titleTrials
dc.date.updated2021-09-24T06:54:23Z
curtin.note

© The Author(s). 2021 Published in Trials. This article is published under the Open Access publishing model and distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/. Please refer to the licence to obtain terms for any further reuse or distribution of this work.

curtin.departmentEnAble Institute
curtin.accessStatusOpen access
curtin.facultyFaculty of Health Sciences
curtin.contributor.orcidMyers-Franchi, Bronwyn [0000-0003-0235-6716]
curtin.identifier.article-numberARTN 440
dcterms.source.eissn1745-6215
curtin.contributor.scopusauthoridMyers-Franchi, Bronwyn [7202684194]


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/